WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Website Revenue Friday, July 19, 2019 
Add Press Release News | News Feeds Feeds | Email This News Email

Molecular Therapy Impact Factors Jump Nearly 28 Percent Across Family of Titles
Wednesday, June 26, 2019

Parent journal, Molecular Therapy, now tops the field with a 19.9 percent jump in impact factor to 8.402.

MILWAUKEE, June 26, 2019 /PRNewswire-PRWeb/ -- The latest impact factor scores for the Molecular Therapy family of journals, the official journals of the American Society of Gene & Cell Therapy (ASGCT), rose by a collective average of 27.9 percent when released on Thursday, June 20.

Impact factors, which measure the frequency with which an average article has been cited in a journal, rank research titles against one another to determine leading journals around the world.

The impact factor of Molecular Therapy, ASGCT's first and primary journal, rose 19.9 percent to 8.402 and remains the top journal in the field. Elsewhere in the Molecular Therapy family, Molecular Therapy-Oncolytics and Molecular Therapy-Methods & Clinical Development earned the largest percentage increases (54.7 and 32.4 percent, respectively) across publisher Cell Press' entire portfolio. Oncolytics also jumped 48 places in overall rank in the Oncology category, from a rank of 85 to 37. The Molecular Therapy family of journals are now the top-ranked journals in the field.

Overall growth in the Molecular Therapy family of journals are as follows:

    --  Molecular Therapy: 8.402 (+19.9 percent)
    --  Molecular Therapy-Nucleic Acids: 5.919 (+4.6 percent)
    --  Molecular Therapy-Oncolytics: 5.71 (+54.7 percent)
    --  Molecular Therapy-Methods & Clinical Development: 4.875 (+32.4 percent)

The American Society of Gene & Cell Therapy is the primary professional membership organization for scientists, physicians, patient advocates, and other professionals with interest in gene and cell therapy. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, biotechnology and pharmaceutical companies. ASGCT advances knowledge, awareness, and education leading to the discovery and clinical application of gene and cell therapies to alleviate human disease to benefit patients and society.

SOURCE Molecular Therapy

Email This News Email | Submit To Slashdot Slashdot | Submit To Digg | Submit To | News Feeds Feeds

Nav Dragon's Press Is Proud to Announce the Upcoming Release of: "Mohammad's Betrayal of Islam" | Jul 19, 2019
Nav Shibadong village: where targeted poverty alleviation began | Jul 19, 2019
Nav OfferUp Debuts 'Hold Offers' Feature To Reserve Items and Reduce Flaky Buyers and Sellers | Jul 18, 2019
Nav geekspeak Commerce Partners with Clearbanc to Make Funding More Accessible for Online Entrepreneurs | Jul 18, 2019
Nav U.S. Healthcare Organizations Face New and Unique Data Security Risks with Digital Transformation Initiatives | Jul 17, 2019
Nav New, Rapidly Growing Fraud Technique Costing U.S. Businesses $50 Billion Per Year | Jul 17, 2019
Nav Payment Security Markets, 2019 to 2024 - Major Players are CyberSource Corporation, Braintree Payment Solutions, Ingenico Group, and Elavon | Jul 17, 2019
Nav Tellables Showcases Conversational Audio Stories at VOICE Summit 2019 | Jul 17, 2019
Nav Introduces Dollar Scholar, A New Weekly Newsletter Conquering Financial Issues Faced By Millennials | Jul 17, 2019
Nav Expands "Travel Now, Pay Later" Option | Jul 17, 2019

Submit News | View More News View More News